Literature DB >> 18299411

Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan.

Hsiu-Mei Wu1, Rajendra Prasad Janapatla, Yueh-Ren Ho, Kuei-Hsiang Hung, Chi-Wen Wu, Jing-Jou Yan, Jiunn-Jong Wu.   

Abstract

Of 1,994 group B streptococcal isolates collected, 26 (1.3%) of the isolates were resistant to levofloxacin, and cross-resistance to other fluoroquinolones was observed. The emergence and prevalence of high-level fluoroquinolone resistance in genetically unrelated isolates were linked to the presence of gyrA, parC, and parE triple mutations in each isolate.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18299411      PMCID： PMC2346645          DOI： 10.1128/AAC.00035-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  [Guidelines on antimicrobial therapy of pneumonia in Taiwan. The Infectious Diseases Society of the Republic of China].

Authors: 
Journal:  J Microbiol Immunol Infect       Date:  1999-12       Impact factor: 4.399

Review 2.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 3.  Mechanisms of resistance to quinolones.

Authors:  George A Jacoby
Journal:  Clin Infect Dis       Date:  2005-07-15       Impact factor: 9.079

4.  Prevalence of Ile-460-Val/ParE substitution in clinical Streptococcus pneumoniae isolates that were less susceptible to fluoroquinolones.

Authors:  Kumiko Kawamura-Sato; Tadao Hasegawa; Keizo Torii; Hideo Ito; Michio Ohta
Journal:  Curr Microbiol       Date:  2005-05-31       Impact factor: 2.188

5.  Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes.

Authors:  Surbhi Malhotra-Kumar; Christine Lammens; Sabine Chapelle; Cecile Mallentjer; Joost Weyler; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2005-02-10       Impact factor: 5.790

6.  Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance.

Authors:  S S Yan; M L Fox; S M Holland; F Stock; V J Gill; D P Fedorko
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

7.  Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci.

Authors:  I González; M Georgiou; F Alcaide; D Balas; J Liñares; A G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

Review 8.  Fluoroquinolone resistance among Gram-positive cocci.

Authors:  David C Hooper
Journal:  Lancet Infect Dis       Date:  2002-09       Impact factor: 25.071

9.  Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).

Authors:  Douglas J Biedenbach; Mark A Toleman; Timothy R Walsh; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2006-03-10       Impact factor: 2.803

10.  First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

Authors:  Yoshiaki Kawamura; Hiromitsu Fujiwara; Noriko Mishima; Yuko Tanaka; Ayako Tanimoto; Shiro Ikawa; Youko Itoh; Takayuki Ezaki
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191
View more
  6 in total

1.  Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.

Authors:  G Piccinelli; F Gargiulo; S Corbellini; G Ravizzola; C Bonfanti; A Caruso; M A De Francesco
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

2.  High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.

Authors:  Hui Wang; Chunjiang Zhao; Wenqiang He; Feifei Zhang; Liyan Zhang; Bin Cao; Ziyong Sun; Yingchun Xu; Qing Yang; Yaning Mei; Bijie Hu; Yunzhuo Chu; Kang Liao; Yunsong Yu; Zhidong Hu; Yuxing Ni
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

3.  Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea.

Authors:  M Ki; U Srinivasan; K Y Oh; M Y Kim; J-H Shin; H L Hong; T Dang; Z Britt; B Foxman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-04       Impact factor: 3.267

4.  Efflux-mediated resistance identified among norfloxacin resistant clinical strains of group B Streptococcus from South Korea.

Authors:  Trang Nguyen Doan Dang; Usha Srinivasan; Zachary Britt; Carl F Marrs; Lixin Zhang; Moran Ki; Betsy Foxman
Journal:  Epidemiol Health       Date:  2014-10-11

5.  High Prevalence of Macrolide-resistance and Molecular Characterization of Streptococcus pyogenes Isolates Circulating in China from 2009 to 2016.

Authors:  Binghuai Lu; Yujie Fang; Yanyan Fan; Xingchun Chen; Junrui Wang; Ji Zeng; Yi Li; Zhijun Zhang; Lei Huang; Hongxia Li; Dong Li; Fengxia Zhu; Yanchao Cui; Duochun Wang
Journal:  Front Microbiol       Date:  2017-06-08       Impact factor: 5.640

6.  Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia.

Authors:  Musa Mohammed Ali; Yimtubezinash Woldeamanuel; Daniel Asrat; Demissie Assegu Fenta; Bernard Beall; Stephanie Schrag; Lesley McGee
Journal:  BMC Infect Dis       Date:  2020-11-16       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.